Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Report

Global and Region Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：206
  • REPORT CODE：GMM942668
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Transient Receptor Potential Cation Channel Subfamily V Member 1 market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Transient Receptor Potential Cation Channel Subfamily V Member 1market, defines the market attractiveness level of Transient Receptor Potential Cation Channel Subfamily V Member 1 market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Transient Receptor Potential Cation Channel Subfamily V Member 1 industry, describes the types of Transient Receptor Potential Cation Channel Subfamily V Member 1 market, the applications of major players and the market size, and deeply analyzes the current situation of the global Transient Receptor Potential Cation Channel Subfamily V Member 1 market and the development prospects and opportunities of Transient Receptor Potential Cation Channel Subfamily V Member 1 industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Transient Receptor Potential Cation Channel Subfamily V Member 1 market in Chapter 13.

    By Player:

    • Medifron DBT Co Ltd

    • Pila Pharma AB

    • Amgen Inc

    • Flex Pharma Inc

    • BCN Peptides SA

    • Amorepacific Corp

    • Kyowa Hakko Kirin Co Ltd

    • Grunenthal GmbH

    • Vitality Biopharma Inc

    • Daewoong Pharmaceutical Co Ltd

    • DoNatur GmbH

    • Toray Industries Inc

    • Sylentis SAU

    • Neurim Pharmaceuticals Ltd

    • Centrexion Therapeutics Corp

    By Type:

    • CMX-020

    • CA-016

    • DD-04107

    • Others

    By End-User:

    • Ophthalmology

    • Immunology

    • Muscle Spasm

    • Pruritus

    • Abdominal Pain

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Analysis and Outlook to 2022

    • 7.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

    • 7.2 United States Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

    • 7.3 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

    • 7.4 China Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

    • 7.5 Japan Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

    • 7.6 India Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

    • 7.7 South Korea Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

    8 Region and Country-wise Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Analysis and Outlook to 2028

    • 8.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

    • 8.2 United States Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

    • 8.3 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

    • 8.4 China Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

    • 8.5 Japan Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

    • 8.6 India Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

    • 8.7 South Korea Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

    9 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Outlook by Types and Applications to 2022

    • 9.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global CMX-020 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global CA-016 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global DD-04107 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Ophthalmology Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Immunology Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Muscle Spasm Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Pruritus Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Abdominal Pain Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Outlook by Types and Applications to 2028

    • 10.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global CMX-020 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global CA-016 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global DD-04107 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Ophthalmology Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Immunology Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Muscle Spasm Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Pruritus Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Abdominal Pain Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.6 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Competitive Analysis

    • 14.1 Medifron DBT Co Ltd

      • 14.1.1 Medifron DBT Co Ltd Company Details

      • 14.1.2 Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Service

    • 14.2 Pila Pharma AB

      • 14.2.1 Pila Pharma AB Company Details

      • 14.2.2 Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Service

    • 14.3 Amgen Inc

      • 14.3.1 Amgen Inc Company Details

      • 14.3.2 Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Service

    • 14.4 Flex Pharma Inc

      • 14.4.1 Flex Pharma Inc Company Details

      • 14.4.2 Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Service

    • 14.5 BCN Peptides SA

      • 14.5.1 BCN Peptides SA Company Details

      • 14.5.2 BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Service

    • 14.6 Amorepacific Corp

      • 14.6.1 Amorepacific Corp Company Details

      • 14.6.2 Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Service

    • 14.7 Kyowa Hakko Kirin Co Ltd

      • 14.7.1 Kyowa Hakko Kirin Co Ltd Company Details

      • 14.7.2 Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Service

    • 14.8 Grunenthal GmbH

      • 14.8.1 Grunenthal GmbH Company Details

      • 14.8.2 Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Service

    • 14.9 Vitality Biopharma Inc

      • 14.9.1 Vitality Biopharma Inc Company Details

      • 14.9.2 Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Service

    • 14.10 Daewoong Pharmaceutical Co Ltd

      • 14.10.1 Daewoong Pharmaceutical Co Ltd Company Details

      • 14.10.2 Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Service

    • 14.11 DoNatur GmbH

      • 14.11.1 DoNatur GmbH Company Details

      • 14.11.2 DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Service

    • 14.12 Toray Industries Inc

      • 14.12.1 Toray Industries Inc Company Details

      • 14.12.2 Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Service

    • 14.13 Sylentis SAU

      • 14.13.1 Sylentis SAU Company Details

      • 14.13.2 Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Service

    • 14.14 Neurim Pharmaceuticals Ltd

      • 14.14.1 Neurim Pharmaceuticals Ltd Company Details

      • 14.14.2 Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Service

    • 14.15 Centrexion Therapeutics Corp

      • 14.15.1 Centrexion Therapeutics Corp Company Details

      • 14.15.2 Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Transient Receptor Potential Cation Channel Subfamily V Member 1

    • Figure Transient Receptor Potential Cation Channel Subfamily V Member 1 Picture

    • Table Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption by Country (2017-2022)

    • Figure United States Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Table Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure China Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure Japan Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure India Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure South Korea Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast by Country (2022-2028)

    • Figure United States Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CMX-020 Consumption and Growth Rate (2017-2022)

    • Figure Global CA-016 Consumption and Growth Rate (2017-2022)

    • Figure Global DD-04107 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Ophthalmology Consumption and Growth Rate (2017-2022)

    • Figure Global Immunology Consumption and Growth Rate (2017-2022)

    • Figure Global Muscle Spasm Consumption and Growth Rate (2017-2022)

    • Figure Global Pruritus Consumption and Growth Rate (2017-2022)

    • Figure Global Abdominal Pain Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global CMX-020 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CA-016 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global DD-04107 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ophthalmology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Muscle Spasm Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pruritus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Abdominal Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Export by Region (Top 5 Countries) (2017-2028)

    • Table Medifron DBT Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Service

    • Table Pila Pharma AB (Foundation Year, Company Profile and etc.)

    • Table Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Service

    • Table Amgen Inc (Foundation Year, Company Profile and etc.)

    • Table Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Service

    • Table Flex Pharma Inc (Foundation Year, Company Profile and etc.)

    • Table Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Service

    • Table BCN Peptides SA (Foundation Year, Company Profile and etc.)

    • Table BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Service

    • Table Amorepacific Corp (Foundation Year, Company Profile and etc.)

    • Table Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Service

    • Table Kyowa Hakko Kirin Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Service

    • Table Grunenthal GmbH (Foundation Year, Company Profile and etc.)

    • Table Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Service

    • Table Vitality Biopharma Inc (Foundation Year, Company Profile and etc.)

    • Table Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Service

    • Table Daewoong Pharmaceutical Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Service

    • Table DoNatur GmbH (Foundation Year, Company Profile and etc.)

    • Table DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Service

    • Table Toray Industries Inc (Foundation Year, Company Profile and etc.)

    • Table Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Service

    • Table Sylentis SAU (Foundation Year, Company Profile and etc.)

    • Table Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Service

    • Table Neurim Pharmaceuticals Ltd (Foundation Year, Company Profile and etc.)

    • Table Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Service

    • Table Centrexion Therapeutics Corp (Foundation Year, Company Profile and etc.)

    • Table Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US